Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Edderd who wrote (11540)	7/15/1998 8:02:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Ed, I would love to get over $20.00/share. But buy back prices are not necessarily a reflection on current prices. I think most here would agree that the price suffers more from perception than future earnings potential (and this is exactly what the shorts have capitalized on). I don't know what they paid for stock in 1997 but the shares purchased in Q1 averaged about $14.50/share which means that management thought that was a reasonable price. Many here have bashed management for paying that much when the price went below 10 but I bet that those same people are in at an average above $14.50/share.